摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-acetoxy-1,2-dihydrogalanthamine | 53375-68-1

中文名称
——
中文别名
——
英文名称
3-acetoxy-1,2-dihydrogalanthamine
英文别名
acetyllycoramine;3β-acetoxy-6-methoxy-10-methyl-galanthamane;3β-Acetoxy-6-methoxy-10-methyl-galanthaman;[(1R,12S,14S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9-trien-14-yl] acetate
3-acetoxy-1,2-dihydrogalanthamine化学式
CAS
53375-68-1
化学式
C19H25NO4
mdl
——
分子量
331.412
InChiKey
ZEHNNDFENRTJFB-QOKNQOGYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    48
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    加兰他敏 在 palladium on activated charcoal 4-二甲氨基吡啶氢气 作用下, 以 甲醇二氯甲烷 为溶剂, 25.0 ℃ 、275.79 kPa 条件下, 反应 11.17h, 生成 3-acetoxy-1,2-dihydrogalanthamine
    参考文献:
    名称:
    Chemical and pharmacological characterization of galanthamine, an acetylcholinesterase inhibitor, and its derivatives. A potential application in Alzheimer's disease?
    摘要:
    We conducted structural and pharmacological studies of galanthamine, a cortical acetylcholinesterase (AChE) inhibitor, and 19 structural analogs. Systematic derivatization of galanthamine at the cyclohexene ring, tertiary amino, hydroxyl and methoxyl functions indicated that these structural features are essential for biological activity. Molecular modeling studies suggested that the low energy conformations of the analogs are similar to that of the parent. One derivative, galanthamine n-butyl carbamate, had an LD50 of over 100 mg/kg (ip) in mice. In a passive avoidance paradigm, this analog improved performance in a dose-dependent fashion with a peak effect at 0.1 mg/kg in control and 0.5 mg/kg in basal forebrain lesioned mice. In the same paradigm, the peak effect of the parent compound is a 6-fold higher dose. With this surprinsingly high therapeutic ratio, this compound may be of interest in treating cholinergic deficits of the central nervous system such as Alzheimer's disease.
    DOI:
    10.1016/0223-5234(92)90087-h
点击查看最新优质反应信息